Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Daisuke Kashiwabara"'
Autor:
Masashi Shiiba, Hitomi Yamagami, Tadashi Sudo, Yosuke Tomokuni, Daisuke Kashiwabara, Tadaaki Kirita, Jingo Kusukawa, Masamichi Komiya, Kanchu Tei, Yoshimasa Kitagawa, Yutaka Imai, Hitoshi Kawamata, Hiroki Bukawa, Kazuhito Satomura, Hidero Oki, Keiji Shinozuka, Kazumasa Sugihara, Tsuyoshi Sugiura, Joji Sekine, Hidetaka Yokoe, Kengo Saito, Hideki Tanzawa
Publikováno v:
Heliyon, Vol 6, Iss 8, Pp e04601- (2020)
S-1 is an anticancer agent that is comprised of tegafur, gimeracil, and oteracil potassium, and is widely used in various carcinomas including oral squamous cell carcinoma (OSCC). Although an established prediction tool is not available, we aimed to
Externí odkaz:
https://doaj.org/article/21398c182c60418db47d4320cc121ecc
Autor:
Ryoji Usami, Ichiro Suzuki, Yuta Kawasaki, Minoru Takeda, Izuru Kawamura, Masato Katahira, Tadashi Nittami, Daisuke Kashiwabara, Daisuke Kan, Keiko Kondo, Michio Sato
Publikováno v:
International Journal of Biological Macromolecules. 183:992-1001
Sphaerotilus natans is a filamentous sheath-forming bacterium commonly found in activated sludge. Its sheath is assembled from a thiolic glycoconjugate called thiopeptidoglycan. S. montanus ATCC-BAA-2725 is a sheath-forming member of stream biofilms,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d3cc7656ad776c585061bc76dbe28d1
https://doi.org/10.1016/j.ijbiomac.2021.05.001
https://doi.org/10.1016/j.ijbiomac.2021.05.001
Autor:
Joji Sekine, Kanchu Tei, Hidetaka Yokoe, Hideki Tanzawa, Yoshimasa Kitagawa, Keiji Shinozuka, Kazumasa Sugihara, Yosuke Tomokuni, Hidero Oki, Masamichi Komiya, Yutaka Imai, Tadaaki Kirita, Tsuyoshi Sugiura, Hitomi Yamagami, Tadashi Sudo, Daisuke Kashiwabara, Hitoshi Kawamata, Hiroki Bukawa, Masashi Shiiba, Kazuhito Satomura, Kengo Saito, Jingo Kusukawa
Publikováno v:
Heliyon, Vol 6, Iss 8, Pp e04601-(2020)
Heliyon
Heliyon
S-1 is an anticancer agent that is comprised of tegafur, gimeracil, and oteracil potassium, and is widely used in various carcinomas including oral squamous cell carcinoma (OSCC). Although an established prediction tool is not available, we aimed to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a21fe4793350b5b9b0d9f7314f0bf8d5
http://ir.lib.shimane-u.ac.jp/52690
http://ir.lib.shimane-u.ac.jp/52690
Autor:
Kohei Kaku, Shigeru Kageyama, Toshiaki Hanafusa, Ryuzo Kawamori, Daisuke Kashiwabara, Nigishi Hotta
Publikováno v:
Journal of Diabetes Investigation. 3:302-308
Aims/Introduction: Repaglinide is a short-acting insulin secretagogue. We assessed the efficacy and safety of repaglinide in comparison with nateglinide in Japanese patients with type 2 diabetes previously treated with diet and exercise. Materials an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2acb1ffe69a0eaa62b19b92883cc2c5b
https://doi.org/10.1111/j.2040-1124.2011.00188.x
https://doi.org/10.1111/j.2040-1124.2011.00188.x
Autor:
Ryuzo, Kawamori, Kohei, Kaku, Toshiaki, Hanafusa, Daisuke, Kashiwabara, Shigeru, Kageyama, Nigishi, Hotta
Publikováno v:
Journal of Diabetes Investigation
Aims/Introduction: Repaglinide is a short‐acting insulin secretagogue. We assessed the efficacy and safety of repaglinide in comparison with nateglinide in Japanese patients with type 2 diabetes previously treated with diet and exercise. Materials
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ab25bdfdd3cacb80566cf31150cc3459
https://pubmed.ncbi.nlm.nih.gov/24843581
https://pubmed.ncbi.nlm.nih.gov/24843581